Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
3
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
South Korean military plans to launch new division for future warfare
-
7
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
8
Teen smoking, drinking decline, while mental health, dietary habits worsen
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
North Korean leader ‘convinced’ dialogue won’t change US hostility
Janssen Korea said Thursday that its schizophrenia medication Invega Sustenna will be covered by national health insurance from Oct. 1.
It means insured patients can buy one month dose of the drug at reduced prices which vary from 12,000 won ($10) to 34,000 won depending on the severity of symptoms.
According to the drug maker, the medicine is proven to ease symptoms of schizophrenia significantly and can be used to lessen the recurrence of schizophrenia symptoms after a long latency.
(baejisook@heraldcorp.com)
It means insured patients can buy one month dose of the drug at reduced prices which vary from 12,000 won ($10) to 34,000 won depending on the severity of symptoms.
According to the drug maker, the medicine is proven to ease symptoms of schizophrenia significantly and can be used to lessen the recurrence of schizophrenia symptoms after a long latency.
(baejisook@heraldcorp.com)
